Chemotherapy: Open Access
Open Access

Hanafy AS (2016) Efficacy of low dose capecitabine and sorafenib in patients with advanced alfa-fetoprotein secreting hepatocellular carcinoma: a 1 year experience. SpringerPlus 5: 1675.

Sousa JL (2014) Toxicity of the antitumor drug mitoxantrone in pediatric and adult mice.

Renner P, Horneber M (2015) CAM-Cancer Consortium. L-Carnitine.

Aysan E, Bayrak OF, Aydemir E, Telci D, Sahin F, et al. (2013) cancer preventive effects of whole cell type immunization against mice Ehrlich tumors. Asian Pacific Journal of Cancer Prevention 14: 3515-3519.

Roesmann A, Afify M, Panse J, Eisert A, Steitz J, et al. (2013) L-carnitine ameliorates L-asparaginase-induced acute liver toxicity in steatotic rat livers. Chemotherapy 59: 167-75.

Dores-Sousa JL, Duarte JA, Seabra V, de Lourdes Bastos M, Carvalho F, et al. (2015) The age factor for mitoxantrone’s cardiotoxicity: multiple doses render the adult mouse heart more susceptible to injury. Toxicology 329: 106-19.

Prasanthi D (2016) Anticancer Drugs used in Treatment of Curing Cancer. Research & Reviews: Journal of Pharmacology and Toxicological Studies 4: 1-7

Durosinmi MA (2016) Burkitt Lymphoma: A Potentially Curable Childhood Tumour: Experience in Ile-Ife, Nigeria (1986-2014). Annals of Health Research 2: 1-9.

Costello LC, Franklin RB (2017) Decreased zinc in the development and progression of malignancy: an important common relationship and potential for prevention and treatment of carcinomas. Expert opinion on therapeutic targets 21: 51-66.

Dezortova M, Jiru F, Skoch A, Capek V, Ryznarova Z, et al. (2016) The aging effect on prostate metabolite concentrations measured by 1H MR spectroscopy. Magnetic Resonance Materials in Physics, Biology and Medicine 13: 1-0.

Vella V, Malaguarnera R, Lappano R, Maggiolini M, Belfiore A, et al. (2016) Recent views of heavy metals as possible risk factors and potential preventive and therapeutic agents in prostate cancer. Molecular and Cellular Endocrinology 20.

Denoyer D, Pearson HB, Clatworthy SA, Smith ZM, Francis PS, et al. (2016) Copper as a target for prostate cancer therapeutics: copper-ionophore pharmacology and altering systemic copper distribution. Oncotarget 7: 37064.

Costello LC, Zou J, Franklin RB (2016) In situ clinical evidence that zinc levels are decreased in breast invasive ductal carcinoma. Cancer Causes & Control 27: 729-35.

Septiawan AD, Kodariah R, Saraswati M (2016) Analysis expression of ZIP1 and caspase-3 protein in adenocarsinoma of the prostate. Makara Journal of Health Research 13:18-22.

Costello LC, Franklin RB (2016) A comprehensive review of the role of zinc in normal prostate function and metabolism; and its implications in prostate cancer. Archives of biochemistry and biophysics 611: 100-12.

Franklin RB, Zou J, Zheng Y, Naslund MJ, Costello LC, et al. (2016) Zinc ionophore (clioquinol) inhibition of human zip1-deficient prostate tumor growth in the mouse ectopic xenograft model: a zinc approach for the Efficacious treatment of prostate cancer. International journal of cancer and clinical research 3: 37.

Mounika M (2016) Review on: Adverse Drug Reactions of Chemotherapy Drugs. Review on: Adverse Drug Reactions of Chemotherapy Drugs. Research & Reviews: Journal of Pharmacology and Toxicological Studies 4: 1-9.

Surai PF (2015) ANTIOXIDANT SYSTEMS IN POULTRY BIOLOGY: HEAT SHOCK PROTEINS. Journal of Science 5: 1188-1222.

Thakur, Chetna (2016) Gene Therapy for Cancer Treatment.Research & Reviews: Journal of Medical and Health Sciences 5: 1-5.

Sunaree C (2015) Gene cloning and characterization of mreb and ftsz from bacillus subtilis.